Results 71 to 80 of about 184,390 (149)

Is COVID-19 acute respiratory distress syndrome-induced consumption leukocytopenia the possible cause of delayed sepsis?

Journal of Indira Gandhi Institute of Medical Sciences
The adaptive immune response is crucial in limiting SARS-CoV-2 infections. The body's immune system becomes hyperinflated when infected organs are not eradicated, which results in a cytokine storm.
Amarjeet Kumar, Abhyuday Kumar, Neeraj Kumar, Kunal Singh, Veena Singh   +4 more
doaj   +1 more source

Current Status of Gene Engineering Cell Therapeutics

Frontiers in Immunology, 2018
Ex vivo manipulations of autologous patient’s cells or gene-engineered cell therapeutics have allowed the development of cell and gene therapy approaches to treat otherwise incurable diseases.
Aurore Saudemont, Laurent Jespers, Timothy Clay   +2 more
doaj   +1 more source

Biological Characteristics and Antitumor Activity of CIK Cells Activated by Recombinant Human Fibronectin for Human Lung Cancer Cell Lines In Vitro

Chinese Journal of Lung Cancer, 2010
Background and objective The CIK cell is one of the most important means of the adoptive cellular immunotherapy, and it is a hotspot of which to simplify its culture procedure and to promote its inhibition rate.
Jialing WANG, Zhe ZHANG, Sa LIU, Yunfeng YANG, Ying HE, Yuan ZHANG, Tuya WULAN, Hui ZHANG, Weili DU, Shiyong WANG   +9 more
doaj  

Growth of Human Colorectal Cancer SW1116 Cells Is Inhibited by Cytokine-Induced Killer Cells

Clinical and Developmental Immunology, 2011
Previous reports have suggested that treatment with cytokine-induced killer (CIK) cells may benefit patients with various types of tumor. The aim of this study was to evaluate the antitumor effects of CIK cells against the colorectal cancer line SW1116 ...
Yao Wang, Hanren Dai, Hong Li, Haiyan Lv, Tao Wang, Xiaobing Fu, Weidong Han   +6 more
doaj   +1 more source

Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study

Haematologica, 2017
Despite persistence of leukemic stem cells, patients with chronic myeloid leukemia who achieve and maintain deep molecular responses may successfully stop the tyrosine kinase inhibitor imatinib.
Delphine Rea, Guylaine Henry, Zena Khaznadar, Gabriel Etienne, François Guilhot, Franck Nicolini, Joelle Guilhot, Philippe Rousselot, Françoise Huguet, Laurence Legros, Martine Gardembas, Viviane Dubruille, Agnès Guerci-Bresler, Aude Charbonnier, Frédéric Maloisel, Jean-Christophe Ianotto, Bruno Villemagne, François-Xavier Mahon, Hélène Moins-Teisserenc, Nicolas Dulphy, Antoine Toubert   +20 more
doaj   +1 more source

Anti-cancer activity of Angelica gigas by increasing immune response and stimulating natural killer and natural killer T cells

BMC Complementary and Alternative Medicine, 2018
Background The polysaccharide component of Angelica gigas induces immuno-stimulatory effects on innate immune cells. However, it is unclear whether A. gigas’ adjuvant activity on the immune system can elicit anti-cancer responses. Methods A water-soluble
Seo Hyun Kim, Sung Won Lee, Hyun Jung Park, Sang Hee Lee, Won Kyun Im, Young Dong Kim, Kyung Hee Kim, Sang Jae Park, Seokmann Hong, Sung Ho Jeon   +9 more
doaj   +1 more source

Post-operative adjuvant immunotherapy with cytokine-induced killer and dendritic cells for hepatocellular carcinoma: A systematic review and meta-analysis

Asian Journal of Surgery, 2023
Huijun Guo, Yun Meng, Jiangshan Peng, Xiaojun Yang   +3 more
doaj   +1 more source

Recent advances in adoptive cell therapy for cancer immunotherapy

Frontiers in Immunology
Adoptive cell therapy (ACT), a key direction in tumor immunotherapy, has achieved remarkable progress in recent years. This paper systematically reviews the current status and future trends of ACT, covering lymphokine-activated killer cells (LAK), tumor ...
Jiameng Qian, Jiameng Qian, Yuhua Liu, Yuhua Liu   +3 more
doaj   +1 more source

The Immune System [PDF]

, 1995
Modern biotherapy has been in use for some 30 years. The first types of biotherapy were nonspecific stimulators of the immune response, but advances in genetic engineering are allowing the mass production of pure biological products which are now being ...
Gallucci, Betty Bierut, McCarthy, Donna O.   +1 more
core   +1 more source

Androgen receptor agonist and antagonist reduce response of cytokine-induced killer cells on prostate cancer cells. [PDF]

J Cell Mol Med, 2023
Pungsrinont T, Schneider MA, Baniahmad A.   +2 more
europepmc   +1 more source